Neuro-rehab innovator Bioxtreme has launched Dextreme 2.0, an enhanced version of its robotic rehabilitation platform that combines patented Error Augmentation technology, adaptive AI and immersive 3D therapy to accelerate motor recovery after stroke and other neurological injury.
The company, based in Petach Tikva, Israel, says the next-generation system is designed to improve upper-extremity recovery in people affected by stroke and other neurological conditions — and that clinical studies of its underlying approach have shown up to twice the improvement of standard robotic therapy.
Both FDA-registered and CE-registered, Dextreme 2.0 brings together Bioxtreme’s patented Error Augmentation technology, adaptive artificial intelligence and immersive 3D therapy experiences to speed up motor learning and improve movement accuracy.
Turning errors into therapy
What sets the platform apart is its core philosophy. Where traditional robotic rehabilitation systems guide a patient’s movement, Dextreme 2.0 does the opposite — strategically amplifying movement errors to activate the brain’s natural adaptive responses and encourage patients to develop more accurate, functional movement patterns. The approach is designed to support faster motor learning while driving meaningful gains in independence.
Clinical studies have demonstrated significant benefits from Error Augmentation-based rehabilitation, including up to 2x greater improvement in Fugl-Meyer scores compared to standard robotic therapy for people recovering from stroke.
What’s new in Dextreme 2.0
The upgraded platform introduces a range of enhancements aimed at widening access and deepening clinical insight:
- Movement scaling — movements are automatically scaled and personalised to each patient’s functional capacity, enabling even those with limited range of motion to actively engage in therapy.
- Arm support — built in to extend accessibility to a wider range of patients.
- Expanded therapy content — a broad set of new ADL-focused and gamified activities designed to improve movement accuracy, stability, coordination and speed, while keeping patients engaged.
- Enhanced assessments and measurements — new assessment tools deliver more detailed clinical measurements and objective performance data.
- Enhanced motor system — upgraded motors provide even smoother robotic movement for an improved user experience.
- Personalised therapy playlists — customised game playlists let patients complete sessions more independently, with minimal therapist intervention, while integrated accessibility controls allow simple navigation and response selection through intuitive handle movements.
A ‘smarter way’ to deliver therapy
“Dextreme was built on a simple but powerful idea, that the brain learns best when it is challenged to adapt,” said Eyal Samuel Shachar, CEO of Bioxtreme. “Rather than compensating for errors, Dextreme uses them as a therapeutic tool.
By combining robotics, AI, and neuroscience, Dextreme provides clinicians with a smarter way to deliver intensive, personalized therapy while helping patients regain confidence, function, and independence.”
Bioxtreme positions Dextreme 2.0 as part of its wider mission to harness its proprietary error augmentation approach to accelerate motor recovery and broaden access to high-intensity, personalised neurorehabilitation. More information is available at bioxtremerobotics.com.
